Musculoskeletal Transplant Foundation Inc

Programs: Musculoskeletal transplant foundation, inc. (mtf) provides allograft tissues to the medical community. Mtf is approaching a 30th anniversary on january 30, 2017. Since its inception in 1987, mtf, the nation's leading tissue bank, has received tissue from over 120,000 donors which has been used to treat more than 8 million patients throughout the world. In 2016, mtf recovered tissue from over 4,100 donors for use in musculoskeletal and bone allograft applications, over 4,200 dermal recoveries for use in burn, general, and plastic surgery applications, and over 850 donors for organs and tissues for research. Overall, mtf distributed more than 490,000 units of allograft tissue during 2016. In addition, to this service, mtf donates allograft tissues for research, medical and educational purposes. Mtf's research and develop- ment has continued development of unique tissue forms for orthopadedic and general surgical applications. Mtf continues to seek new applications for the use of the gift of allograft tissues to resolve unmet clinical needs and continues to provide special tissue for research performed by members of the armed forces institute of regenerative medicine which is an organization dedicated to developing medical therapies and treatments for wounded soldiers. In 2016 mtf made significant progress in orthopaedics including sports medicine and spine; successful expansion of tissue forms in plastic and reconstructive surgery and wound care. Highlights of orthopaedic activity include progress in technology that extends the useful date of fresh osteochondral grafts. A new tissue platform was introduced for spine applications with plans to make these tissue forms available in chronic wound care applications. The properties of this tissue provide new options for treatment of surgical and chronic wounds. In plastic and reconstructive surgery, mtf introduced a dehydrated allograft adipose matrix that can be stored at room temperature and hydrated for injection at the time of use. Mtf's dermal tissue line was expanded to include flex hd max to enhance aesthetic outcomes after breast reconstruction surgery. In 2016 mtf improved the time to healing of wound care tissue forms and expanded the reimbursement coverage for the wound care division throughout the united states. In 2015 mtf had continued to invest in field of plastic and reconstructive surgery with the introduction of perforated and shaped forms of flex hd pliable dermis, offering competitive convenience and ease of use for breast reconstruction. The foundation continued with its efforts to expand entry into the wound care market with advanced wound care tissues. Amnioband, dehydrated amnion/chorion membrane based on placental tissue recovery was launched in 2015 for the treatment of diabetic and venous ulcers. Reimbursement was also secured for amnioband and coverage was approved by several medicare administrative contractors during the year. In the orthopedic sports tissue market, mtf launched cam, dehydrated cartilage particles for repair of focal cartilage defects during 2014, mtf had launched mtf wound care-a new mtf division dedicated to researching, developing and providing allograft-based, biologic solutions to treat acute and chronic wounds. Since 2013, mtf, with the support of its recovery partners, joined with the american society of plastic surgeons (asps) and the plastic surgery foundation (psf) in support of national breast reconstruction awareness (bra) day usa in october of each year. As a sponsor, mtf, joined the world's largest organization of board-certified plastic surgeons in a campaign to support breast cancer survivors' rights to make an informed decision when choosing breast reconstruction options. For individual stories of donor families, please visit mtf's website at http://www. Mtf. Org/donor_family_stories. Html and also on its youtube channel at www. Youtube. Com/user/themtf1. Stories about donor recipients are also available on mtf's website at http://www. Mtf. Org/recipient_stories. Html.

mtf pays independent research experts to review grant proposals submitted to the organization for validity or merit of the proposed research project and also relationship to mtf's core mission of advancing musculoskeletal transplant science. During 2016, mtf received 71 applicactions for peer review and other grants, 7 projects were approved for funding.